Form EFFECT AGOMAB THERAPEUTICS NV/A
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:01 P.M. |
| Form: | F-6 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- F.N.B. Corporation Declares Cash Dividend of $0.13 on Common Stock
- Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition
- AM Best Affirms Credit Ratings of Privilege Underwriters Reciprocal Exchange and PURE Specialty Exchange
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
